Shenzhen Neptunus Bioengineering Co

Shenzhen Neptunus Bioengineering Co Dividend per Share

The Dividend per Share of Shenzhen Neptunus Bioengineering Co (000078.SZ) as of Oct 16, 2026 is 0.02 CNY. In the previous year, Dividend per Share was 0.07 CNY — a change of -71.43% (lower).

Dividend per Share

0.02CNY

YoY

-71.43%

Last updated:

Dividend per Share of Shenzhen Neptunus Bioengineering Co is 2019 0.02 CNY. Dividend per Share of Shenzhen Neptunus Bioengineering Co was 2018 0.07 CNY. It decreases by -71.43% lower compared to the previous year.

Shenzhen Neptunus Bioengineering Co currently offers a dividend yield of about 1.49%. The payout ratio is around 23% of earnings.

The Shenzhen Neptunus Bioengineering Co Dividend per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend per Share
Date
Dividend per Share
Jan 1, 2018
0.07 CNY
Jan 1, 2019
0.02 CNY
Jan 1, 2020
0.00 CNY
Jan 1, 2021
0.00 CNY
Jan 1, 2022
0.00 CNY
Jan 1, 2023
0.00 CNY
Jan 1, 2024
0.00 CNY
Jan 1, 2025
0.00 CNY
The Shenzhen Neptunus Bioengineering Co Dividend per Share history
YEARDividend per ShareYoY
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY-100.00%
0.02CNY-71.43%
0.07CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shenzhen Neptunus Bioengineering Co Stock analysis

What does Shenzhen Neptunus Bioengineering Co do? Shenzhen Neptunus Bioengineering Co Ltd is a company based in Shenzhen, China, operating within the Health Care sector. The company has been publicly traded since its IPO on December 18, 1998, with a ticker symbol of 000078.SZ and ISIN CNE000000X95. It employs 9,874 people. The company's primary business involves the pharmaceutical industry, focusing on the development and distribution of various medical products. Its main product categories include anti-tumor medications, cardiovascular drugs, marine-derived pharmaceuticals, respiratory treatments, anti-infective products, and additional pharmaceuticals. The company also offers healthcare products, health food, and medical instruments. Shenzhen Neptunus Bioengineering Co Ltd primarily serves the domestic Chinese market, with a significant focus on the East China region. The company's official website is https://www.neptunusbio.com/. No additional details regarding founding year, specific acquisitions, or financial figures beyond the provided data are included in this profile. Shenzhen Neptunus Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shenzhen Neptunus Bioengineering Co stock

Dividend per Share of Shenzhen Neptunus Bioengineering Co is 0.02 CNY in 2019.

Dividend per Share of Shenzhen Neptunus Bioengineering Co changed from 0.07 CNY to 0.02 CNY, representing a -71.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend per Share Shenzhen Neptunus Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

Dividend per share is the total dividend payment divided by shares outstanding. It shows how much cash each share receives in dividends.

Dividend per Share's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend per Share's Shenzhen Neptunus Bioengineering Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Shenzhen Neptunus Bioengineering Co

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Shenzhen Neptunus Bioengineering Co